Liquiritin ameliorates metabolic and endocrine alterations in a mouse model of polycystic ovary syndrome
Abstract. Objective:. Altered bile acid transformation induces low-grade chronic inflammation and may play an important role in the pathophysiology of polycystic ovary syndrome (PCOS). Liquiritincan regulate bile acid metabolism and anti-inflammatory properties; however, limited information is avail...
Main Authors: | Zhi Li, Yan Liu, Hai-Ou Liu, Zhi-Yong Wu, Cong-Jian Xu, Fei-Fei Zhang, Yong-Qing Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2022-06-01
|
Series: | Reproductive and Developmental Medicine |
Online Access: | http://journals.lww.com/10.1097/RD9.0000000000000025 |
Similar Items
-
Endocrine Disruptors and Polycystic Ovary Syndrome: Phthalates
by: Leyla Akın, et al.
Published: (2020-12-01) -
Time-restricted feeding improves metabolic and endocrine profiles in mice with polycystic ovary syndrome
by: Yan Han, et al.
Published: (2022-12-01) -
Effect of subclinical hypothyroidism on endocrine and metabolic characteristics of patients with polycystic ovary syndrome
by: ZHANG Yuanmou, HAN Kang, XIA Rui, SUN Wenjian, REN Xiaoying, WANG Yan
Published: (2023-04-01) -
Alteration in gut mycobiota of patients with polycystic ovary syndrome
by: Ke Chen, et al.
Published: (2023-10-01) -
Reactive Hypoglycemia: A Trigger for Nutrient-Induced Endocrine and Metabolic Responses in Polycystic Ovary Syndrome
by: Sidika E. Karakas
Published: (2023-11-01)